Home  >  About Us  >  Management Team

Management Team

The TVAX® management team consists of experienced executives with proven track records of success, who together possess the expertise required to conduct clinical studies as well as direct the related scientific and business operations.  Additionally, the team possesses critical manufacturing expertise which will be essential in the scale-up required for ultimate commercialization of the TVAX platform.

Lowell L. Tilzer, M.D., Ph.D., TVAX's interim Chief Executive Officer is a co-founder and has served as a director since 2011. Dr. Tilzer is a board-certified clinical pathologist and is an expert in blood processing. Dr. Tilzer is a Professor in the Department of Pathology and Laboratory Medicine at the University of Kansas Medical Center. He served as Chairperson of that department from 2009 until his retirement from that position in 2015. Prior to 2009, Dr. Tilzer held a series of senior management positions within the Blood Services division of the American Red Cross, including service as chief executive officer of the American Red Cross Southwest Region. Dr. Tilzer received his B.A. from the University of Kansas and his M.D., Ph.D. and Pathology Residency from the University of Kansas Medical Center.

Gary W. Wood, Ph.D., founded TVAX Biomedical in 2004 and currently serves as Chief Scientific Officer and Chairman of the Board of Directors.  He served as President and CEO of the company from the company’s inception until December 2012. Dr. Wood is the inventor and principal developer of the TVAX Immunotherapy® technology. Dr. Wood guided the development of TVAX Immunotherapy from concept through its most recent human clinical trials. Dr. Wood organized and coordinated the Phase 1 / 2 clinical trials performed at University of Kansas Medical Center and at Wayne State University and managed the scientific/clinical teams that performed the trials. Dr. Wood was Professor of Pathology, Director of the Diagnostic Immunology Laboratory and Director of the Cancer Immunotherapy Laboratory at KU Medical Center. Dr. Wood also was Professor of Medicine and Director of the Cancer Immunotherapy Laboratory at Wayne State University. Dr. Wood has a B.A. from Kalamazoo College and a Ph.D. from the State University of New York at Buffalo.

Tammie A. Wahaus, CPA, CGMA, joined TVAX Biomedical in 2012 and serves as our Chief Financial Officer and prior to that provided services as a consultant to the company. Ms. Wahaus is also Chief Executive Officer of Elias Animal Health, a subsidiary of the company. Ms. Wahaus has more than 25 years of experience in both public accounting and private business. She has served as Vice President-Finance for Epiq Systems, Inc., as an audit partner with Ernst & Young LLP providing services to public and private companies and as Controller and Principal Accounting Officer for GE Global Insurance Holding Corporation, a public company. She has a B.S. in Business Administration from Kansas State University.